Engstad C S, Lund T, Osterud B
Department of Biochemistry, Institute of Medical Biology, Faculty of Medicine, University of Tromsø, Norway.
Thromb Haemost. 1999 Jan;81(1):139-45.
Interleukin-8 (IL-8) is generally accepted to be an important mediator of a number of acute and chronic inflammatory diseases and is produced by monocytes upon stimulation by lipopolysaccharide (LPS). Epinephrine has been reported by several groups to suppress activation of monocytes in response to LPS, and the aim of the present study was to examine the effect of epinephrine on LPS induced IL-8 production using whole blood as a model system. Epinephrine increased LPS induced IL-8 production in a dose-dependent manner in the whole concentration range (0.001-100 microM) and 1 microM epinephrine increased IL-8 levels with 125%. Epinephrine per se had no effect on IL-8 levels. The potentiating effect of epinephrine was mediated by blood platelets, since IL-8 levels in samples containing platelets and stimulated with LPS and epinephrine (1-100 microM) were significantly higher (p<0.05) than in control samples containing no platelets. This effect of platelets seemed to be due to platelet release products, since addition of 25 microL platelet lysate supernatant to whole blood increased LPS induced IL-8 production with 100% and a similar effect was observed in freshly isolated mononuclear cells resuspended in plasma. Upon addition of 50 microg/ml of the carboxyterminal peptide of platelet factor 4 (PF4(58-70)) to whole blood, LPS stimulated IL-8 levels were increased with 115%, whereas in mononuclear cells, 20 microg/ml PF4(58-70) enhanced IL-8 production with 40%. We demonstrate for the first time that epinephrine promotes LPS induced production of IL-8 in whole blood via an effect on blood platelets. This potentiating effect of platelets is shown to be due to platelet granule contents, and platelet factor 4 (PF4) is suggested to be one of several platelet granule proteins promoting LPS induced IL-8 production in whole blood.
白细胞介素-8(IL-8)通常被认为是多种急慢性炎症性疾病的重要介质,由单核细胞在脂多糖(LPS)刺激下产生。多个研究小组报告称肾上腺素可抑制单核细胞对LPS的激活,本研究的目的是使用全血作为模型系统,研究肾上腺素对LPS诱导的IL-8产生的影响。在整个浓度范围(0.001 - 100微摩尔)内,肾上腺素以剂量依赖的方式增加LPS诱导的IL-8产生,1微摩尔肾上腺素使IL-8水平增加125%。肾上腺素本身对IL-8水平无影响。肾上腺素的增强作用由血小板介导,因为含有血小板并受到LPS和肾上腺素(1 - 100微摩尔)刺激的样本中的IL-8水平显著高于(p<0.05)不含血小板的对照样本。血小板的这种作用似乎归因于血小板释放产物,因为向全血中添加25微升血小板裂解物上清液可使LPS诱导的IL-8产生增加100%,并且在重新悬浮于血浆中的新鲜分离单核细胞中也观察到类似效果。向全血中添加50微克/毫升的血小板因子4(PF4(58 - 70))的羧基末端肽后,LPS刺激的IL-8水平增加115%,而在单核细胞中,20微克/毫升PF4(58 - 70)使IL-8产生增加40%。我们首次证明肾上腺素通过对血小板的作用促进全血中LPS诱导的IL-8产生。血小板的这种增强作用表明是由于血小板颗粒内容物,并且血小板因子4(PF4)被认为是促进全血中LPS诱导的IL-8产生的几种血小板颗粒蛋白之一。